GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gabather AB (OSTO:GABA) » Definitions » EV-to-Revenue

Gabather AB (OSTO:GABA) EV-to-Revenue : (As of Jun. 03, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Gabather AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Gabather AB's enterprise value is kr9.52 Mil. Gabather AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil. Therefore, Gabather AB's EV-to-Revenue for today is .

The historical rank and industry rank for Gabather AB's EV-to-Revenue or its related term are showing as below:

During the past 11 years, the highest EV-to-Revenue of Gabather AB was 574.17. The lowest was -47.38. And the median was -11.58.

OSTO:GABA's EV-to-Revenue is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.43
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), Gabather AB's stock price is kr0.044. Gabather AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00. Therefore, Gabather AB's PS Ratio for today is .


Gabather AB EV-to-Revenue Historical Data

The historical data trend for Gabather AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gabather AB EV-to-Revenue Chart

Gabather AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Gabather AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Gabather AB's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Gabather AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gabather AB's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gabather AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Gabather AB's EV-to-Revenue falls into.


;
;

Gabather AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Gabather AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=9.515/0
=

Gabather AB's current Enterprise Value is kr9.52 Mil.
Gabather AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gabather AB  (OSTO:GABA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Gabather AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.044/0
=

Gabather AB's share price for today is kr0.044.
Gabather AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gabather AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gabather AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Gabather AB Business Description

Traded in Other Exchanges
N/A
Address
Forskargatan 20J, Byggn 215 N, Sodertalje, SWE, 151 36
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.

Gabather AB Headlines

No Headlines